Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other 4Breast 2Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1Gastrointestinal 1Endocrine 1

Conditions

Breast Neoplasms 13138Triple Negative Breast Neoplasms 1150Neoplasms 750Ovarian Neoplasms 680Neoplasm Metastasis 590Lung Neoplasms 582Colorectal Neoplasms 581Prostatic Neoplasms 560Carcinoma, Non-Small-Cell Lung 536Pancreatic Neoplasms 380Melanoma 366Stomach Neoplasms 350Colonic Neoplasms 330Motor Activity 285Breast Neoplasms, Male 285Carcinoma, Intraductal, Noninfiltrating 277Uterine Cervical Neoplasms 267Head and Neck Neoplasms 266Endometrial Neoplasms 256Carcinoma, Renal Cell 216Sarcoma 204Urinary Bladder Neoplasms 192Squamous Cell Carcinoma of Head and Neck 192Lymphedema 190Esophageal Neoplasms 189Breast Carcinoma In Situ 189Brain Neoplasms 183Fatigue 166Carcinoma, Ovarian Epithelial 151Small Cell Lung Carcinoma 148

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Glucose Intolerance × Breast × Clear all
NCT05038137 2026-06-02

TREC

Medical University of South Carolina

Phase NA Completed
29 enrolled 16 charts
Breast

Intermittent Fasting, Breast Neoplasms, Glucose Intolerance

NCT04210128 2023-11-01

Glucose Monitoring to Predict and Treat High Glucose Levels After Steroid Treatment

Memorial Sloan Kettering Cancer Center

Completed
3 enrolled
BreastGastrointestinal

Breast Neoplasms, Diabetes Mellitus, Pancreatic Neoplasms, Glucose Intolerance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡